GEHC

GE HealthCare Technologies Inc.

$83.65

-0.45%
SectorHealthcareIndustryMedical DevicesCountryUnited States

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions.

Source: Yahoo Finance
AI summary

Price & performance

1M+33.5%
3M+22.2%
YTD+3.8%
1Y+15.7%
52-week range—
Beta1.09
Full chart and returns against a benchmark

Q-Score

66/ 100

Quality against peers; 50 is the peer median.

Growth56
Risk76
Performance50
Valuation71
Profitability65
Leverage46
Sentiment52
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$20.6B+4.8%
Net income$2.1B+4.6%
Net margin10.1%-0.0 pts
Historical fundamentals

Revenue exposure

56%of revenue from outside the US
Other Countries46%
United States44%
China10%
Regions, segments, customers and suppliers

Valuation

GEHCIndustryP/E17.5729.61P/S1.753.49EV/EBITDA14.0718.38P/B3.263.39PEG——
Dividend yield0.17%
Every valuation metric

Earnings

Oct 28next report, before the open
EPS estimate$1.21
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate